METHOD FOR PREDICTING BREAST CANCER RISK IN PATIENTS WITH HEREDITARY BURDEN

摘要

A method for predicting breast cancer risk in the patients with hereditary burden comprises clinico-genealogical analysis. In cases with the genealogical burden, G1934A polymorphism of CYP2D6 gene is studied. *4*4 (A1934A) polymorphism of CYP2D6 gene suggests the increased risk of breast cancer.